NovaBay Pharmaceuticals, Inc. (NBY) Insider Ownership

Historic Insider Ownership Trends

NovaBay Pharmaceuticals's three largest insider shareholders as of March 23, 2026 are Fund Lp R01 (TenPercentOwner, 11.36Mn shares), Ventures Iv L.P. Framework (TenPercentOwner, 11.36Mn shares), Michael John Kazley (Chief Executive Officer, 11.36Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Ventures Iv L.P. Framework 11,361,216 0 03 Nov, 2025
Fund Lp R01 11,361,216 0 03 Nov, 2025
Ventures Iv L.P. Framework 11,361,216 0 03 Nov, 2025
Michael John Kazley Chief Executive Officer 0 11,361,216 03 Nov, 2025
Point Capital Partners Lp Poplar 204,060 0 14 Apr, 2025
Andrew D. Jones Cfo 25,492 0 06 Dec, 2021
Justin Hall Ceo, Gc And Director 16,634 0 16 Sep, 2022
Mijia Wu 343 0 15 May, 2023
Paul E. Freiman 343 0 15 May, 2023
Swan Sit 343 0 15 May, 2023
Yenyou Zheng 343 0 15 May, 2023
Julie Garlikov 172 0 15 May, 2023
Yongxiang Zheng 172 0 15 May, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
21 Oct, 2025 Ventures Iv L.P. Framework Common Stock A 56,806,080 $0.00 11,361,216 D C
21 Oct, 2025 Ventures Iv L.P. Framework Common Stock A 56,806,080 $0.00 11,361,216 D C
21 Oct, 2025 Fund Lp R01 Common Stock A 56,806,080 $0.00 11,361,216 D C
21 Oct, 2025 Michael John Kazley Common Stock A 56,806,080 $0.00 11,361,216 I C
16 Oct, 2025 Ventures Iv L.P. Framework Pre-Funded Warrants (Right to Buy) A 2,702,703 $0.00 540,541 D P
16 Oct, 2025 Ventures Iv L.P. Framework Pre-Funded Warrants (Right to Buy) A 2,702,703 $0.00 540,541 D P
16 Oct, 2025 Fund Lp R01 Pre-Funded Warrants (Right to Buy) A 2,702,703 $0.00 540,541 D P
16 Oct, 2025 Michael John Kazley Pre-Funded Warrants (Right to Buy) A 2,702,703 $0.00 540,541 I P
16 Oct, 2025 Ventures Iv L.P. Framework Series D Non-Voting Convertible Preferred Stock A 220,663 $0.00 44,133 D J
16 Oct, 2025 Ventures Iv L.P. Framework Series D Non-Voting Convertible Preferred Stock A 220,663 $0.00 44,133 D J
16 Oct, 2025 Ventures Iv L.P. Framework Series E Non-Voting Convertible Preferred Stock A 134,375 $0.00 26,875 D J
16 Oct, 2025 Ventures Iv L.P. Framework Series E Non-Voting Convertible Preferred Stock A 134,375 $0.00 26,875 D J
16 Oct, 2025 Fund Lp R01 Series D Non-Voting Convertible Preferred Stock A 220,663 $0.00 44,133 D A
16 Oct, 2025 Ventures Iv L.P. Framework Series D Non-Voting Convertible Preferred Stock A 220,663 $0.00 44,133 D J
16 Oct, 2025 Michael John Kazley Series D Non-Voting Convertible Preferred Stock A 220,663 $0.00 44,133 I A
16 Oct, 2025 Michael John Kazley Series E Non-Voting Convertible Preferred Stock A 134,375 $0.00 26,875 I A
16 Oct, 2025 Fund Lp R01 Series E Non-Voting Convertible Preferred Stock A 134,375 $0.00 26,875 D A
16 Oct, 2025 Ventures Iv L.P. Framework Series E Non-Voting Convertible Preferred Stock A 134,375 $0.00 26,875 D J
16 Oct, 2025 David E. Lazar Series D Convertible Preferred Stock D 441,325 - 7,985 D S
25 Feb, 2025 Point Capital Partners Lp Poplar Common Stock, par value $0.01 per share A 25,033 $0.62 146,041 D P